@article{TLCR23934,
author = {Sharon R. Pine and Bríd M. Ryan},
title = {Identifying therapeutic vulnerabilities in lung cancer: application of a chemistry-first approach},
journal = {Translational Lung Cancer Research},
volume = {7},
number = {Suppl 3},
year = {2018},
keywords = {},
abstract = {In the last three decades, 5-year relative survival rates for lung cancer improved slightly, from 14.3%, 15.5%, and 18.4% (1). One of the reasons for these dismal survival rates is that most patients present with advanced-stage disease, a time during which systemic therapies are unlikely to be curative.},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/23934}
}